Your medical team considers multiple factors including your overall health, other medications, and weight loss pattern when making dosing decisions
Coverage varies, so we recommend checking your out-of-network benefits in advance
In these cases, the clinical decision involves weighing ongoing symptoms against therapeutic benefitsimproved glycemic control, weight loss, and potential cardiovascular benefits demonstrated in specific medications
Group II: reserpine group (Res group): reserpine was given subcutaneously to rats at a dose of 1 mg/kg/day (Yao et al
In the current study, MTX caused a pronounced decline in the dielectric constant, dielectric loss and the conductivity of kidney tissue, which may be attributed to MTX-induced kidney tissue damage